Sustained Asthma Control Over Three Years with Beclometasone/Formoterol/Glycopyrronium: Results from the TriMaximize Study (ERS 2026) - May 30, 2026 - Abstract #PA5835; Pres time: Sep 8, 2026; 12:30 PM - 02:00 PM; Location: PS-14; Board Number: 7; "Asthma control significantly improved after initiation of BDP/FF/G and then remained stable throughout the 3-year follow-up. This indicates that BDP/FF/G therapy is a valuable option for the long-term treatment of asthma patients."
Asthma • Immunology • Respiratory Diseases
|
|
C. Gessner; V. Bogoevska; R. Russell; C. Suppli Ulrik; W. Pohl; V. Plaza; A. Bourdin; M. Kupczyk; F. Braido; C. Fritz; A. Hahn; V. Grickschat; F. Trinkmann
|